v3.26.1
Condensed Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash $ 313,322 $ 881,853
Prepaid expenses 103,995 128,720
Total current assets 417,317 1,010,573
Long-term prepaid insurance 0 100,054
Investments held in Trust Account 120,509,940 100,596,478
Total Assets 120,927,257 101,707,105
Current Liabilities    
Accrued offering costs 75,000 75,000
Accounts payable and accrued expenses 131,622 41,117
Over-allotment option liability 0 147,970
Total Liabilities 206,622 264,087
Commitments and Contingencies (Note 6)
Ordinary shares subject to possible redemption, 11,500,000 and 10,000,000 shares at redemption value of approximately $10.38 and $10.06 per share as of September 30, 2025 and December 31, 2024, respectively 120,509,940 100,596,478
Shareholders' Equity    
Preference shares, $0.0001 par value; 100,000,000 shares authorized; none issued and outstanding 0 0
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 4,537,500 and 4,500,000 issued and outstanding (excluding 11,500,000 and 10,000,000 subject to possible redemption) as of September 30, 2025 and December 31, 2024, respectively [1],[2] 454 450
Additional paid-in capital 0 885,564
Retained Earnings (Accumulated deficit) 210,241 (39,474)
Total Shareholders' Equity 210,695 846,540
Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders' Equity $ 120,927,257 $ 101,707,105
[1] December 31, 2024 includes an aggregate of up to 500,000 ordinary shares subject to forfeiture if the over-allotment was not exercised in full or in part by the underwriters (See Notes 5 and 7).
[2] On January 3, 2025, the underwriters fully exercised their over-allotment option resulting in no shares subject to forfeiture related to the over-allotment option.